Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Identifying biomarkers for diagnosing sepsis in the emergency room

Official title: Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room

Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT06178822 · Data updated 2026-11-12

This study is trying to find out if certain immune responses can help doctors spot sepsis in patients with infections when they arrive at the emergency room.

More Sepsis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment3300 (estimated)
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academic / other
Locations3 sites (Almere Stad, Flevoland and 2 other locations)
StatusRecruiting
StartedOctober 25, 2022
Main results expectedOctober 1, 2026
Study endsOctober 1, 2026
Registry record updatedOctober 2, 2025
Trial IDNCT06178822 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 years or older who present to the emergency department with a clinical suspicion of infection.

Probably not a fit

Patients who do not provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to compare the immune responses of patients with and without sepsis who present to the emergency department with suspected infections. It seeks to identify immune response abnormalities that may indicate an increased risk of developing sepsis in patients initially presenting without it. Additionally, the study will assess the long-term cognitive and physical effects of sepsis on patients after their admission. The research will utilize the SOFA score to define sepsis and will adapt the assessment of respiratory function for emergency settings.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic methods for sepsis, enabling timely and effective treatment for patients.

How similar studies have gone: Other studies have explored biomarkers for sepsis diagnosis, but this specific approach focusing on immune responses in the emergency setting is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or higher
* Presentation at the Emergency Department (ED)
* Clinical suspicion of infection or earlier confirmed infection
* Modified Early Warning Score (MEWS) of 2 or higher

Exclusion Criteria:

* No informed consent given

Where it's running

  • Amsterdam UMC, location VUMC
    Amsterdam, North Holland, Netherlands
    Recruiting
  • Amsterdam UMC, location AMC
    Amsterdam, North Holland, Netherlands
    Recruiting
  • Flevoziekenhuis
    Almere Stad, Flevoland, Netherlands
    Not yet recruiting

Study contacts

  • Principal investigator: Willem Joost Wiersinga, MD, PhD — Amsterdam UMC, location AMC
  • Study coordinator: Oren Turgman, MD, MsC
  • Email: biosep@amsterdamumc.nl
  • Phone: 0205669111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.